ArticleCost effectiveness and resource allocation : C/E2023

Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia.

Yazed AlRuthia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.